FMT

FMT

2939 bookmarks
Custom sorting
Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design - PubMed
Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design - PubMed
The occurrence and development of Parkinson's disease (PD) have been demonstrated to be related to gut dysbiosis, however, the impact of fecal microbiota transplantation (FMT) on microbiota engraftment in PD patients is uncertain. We performed a randomized, placebo-controlled trial at the Department …
·pubmed.ncbi.nlm.nih.gov·
Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Live biotherapeutic products (LBPs) represent a new class of therapeutics indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in adults. However, microbiota-based therapies have been used in CDI management before the Food and Drug Administration (FDA) designated this new …
·pubmed.ncbi.nlm.nih.gov·
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety - PubMed
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety - PubMed
FMT can relieve patients' constipation, depression, and anxiety symptoms by reshaping gut microbiota. The 5-HT level was associated with an altered abundance of specific bacteria or metabolites. This study provides specific evidence for FMT intervention in constipation patients with psychiatric symp …
·pubmed.ncbi.nlm.nih.gov·
Multi-omics analysis of fecal microbiota transplantation's impact on functional constipation and comorbid depression and anxiety - PubMed
Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer - PubMed
Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer - PubMed
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and poses a major burden on the human health worldwide. At the moment, treatment of CRC consists of surgery in combination with (neo)adjuvant chemotherapy and/or radiotherapy. More recently, immune checkpoint blockers (ICBs) have …
·pubmed.ncbi.nlm.nih.gov·
Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer - PubMed
Fecal microbiota transplantation: a novel strategy for treating Alzheimer's disease - PubMed
Fecal microbiota transplantation: a novel strategy for treating Alzheimer's disease - PubMed
Alzheimer's disease is a common neurological disorder, which has become one of the major factors affecting human health due to its serious impact on individuals, families and society. It has been confirmed that gut microbiota can affect the occurrence and development of Alzheimer's disease. Especial …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation: a novel strategy for treating Alzheimer's disease - PubMed
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
Aging is a strong risk factor for colorectal cancer (CRC). It is well established that gut microbial dysbiosis can play a role in the etiology of CRC. Although the composition of the gut microbial community changes with age and is reported to become more pro-inflammatory, it is unclear whether such …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
The gut microbiome has coevolved with humans to aid in physiologic functions and prevent disease. An increasing prevalence of gut dysbiosis in modern society exists and has strong linkages to multiple disease processes common in the developed world. Mechanisms for microbiome-human interactions that …
·pubmed.ncbi.nlm.nih.gov·
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Live biotherapeutic products (LBPs) represent a new class of therapeutics indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in adults. However, microbiota-based therapies have been used in CDI management before the Food and Drug Administration (FDA) designated this new …
·pubmed.ncbi.nlm.nih.gov·
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
The profound impact of the human microbiome on health and disease has captivated the interest of clinical and scientific communities. The human body hosts a vast array of microorganisms collectively forming the human microbiome, which significantly influences various physiological processes and prof …
·pubmed.ncbi.nlm.nih.gov·
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Highlights from NeuroGASTRO 2023. Find out about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
·news.google.com·
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Fecal Microbiota Transplantation: Information for the Pediatrician
Fecal Microbiota Transplantation: Information for the Pediatrician
Fecal microbiota transplantation (FMT) involves the delivery of an entire microbial community from a healthy donor to a recipient with the intention of ameliorating or curing a specific disease. Current evidence strongly supports a role for FMT in the treatment of Clostridiodes difficile infection, with cure rates of approximately 80%...
·news.google.com·
Fecal Microbiota Transplantation: Information for the Pediatrician
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
Background: It is unclear whether the use of selective decontamination of the digestive tract (SDD) improves outcomes in ventilated patients in intensive care units (ICUs) and whether SDD is associated with the development of antibiotic resistance. Objective: To describe the study prot …
·pubmed.ncbi.nlm.nih.gov·
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The Human Microbiome Project (HMP) has raised great expectations claiming the far-reaching influence of the microbiome on human health and disease ranging from obesity and malnutrition to effects going well beyond the gut. So far, with the notable exception of fecal microbiota transplantation in …
·pubmed.ncbi.nlm.nih.gov·
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The Human Microbiome Project (HMP) has raised great expectations claiming the far-reaching influence of the microbiome on human health and disease ranging from obesity and malnutrition to effects going well beyond the gut. So far, with the notable exception of fecal microbiota transplantation in …
·pubmed.ncbi.nlm.nih.gov·
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study
·pubmed.ncbi.nlm.nih.gov·
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
The value of oral microbiome therapy for recurrent C. difficile infection
The value of oral microbiome therapy for recurrent C. difficile infection
A trial assessed a microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. diff infection. Read IDSA’s Journal Club review by Zeina Kanafani MD, MS, CIC, FIDSA.
·news.google.com·
The value of oral microbiome therapy for recurrent C. difficile infection
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
This comprehensive review delves into the intricate relationship between the gut microbiota and multiple sclerosis (MS), shedding light on the potential therapeutic avenues for this complex autoimmune disease. It emphasizes the multifactorial nature of MS, including genetic, environmental, and gende …
·pubmed.ncbi.nlm.nih.gov·
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Inflammatory bowel disease (IBD) is a chronic and idiopathic condition that results in inflammation of the gastrointestinal tract, leading to conditions such as ulcerative colitis and Crohn's disease. Commonly used treatments for IBD include anti-inflammatory drugs, immunosuppressants, and antibioti …
·pubmed.ncbi.nlm.nih.gov·
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Vitamin K1 might ameliorate LPS-triggered skeletal muscle damage by antagonizing NF-κB-mediated inflammation through upregulation of SIRT1 and regulating the balance between protein synthesis and catabolism.
·pubmed.ncbi.nlm.nih.gov·
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
This study was supported by the National Natural Science Foundation of China (82102954 to Wensi Zhao) and the Special Project of Central Government for Local Science and Technology Development of Hubei Province (ZYYD2020000169 to Yongshun Chen).
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
Gut microbiome dysbiosis may be implicated in numerous diseases. Substantial evidence suggests FMT improves clinical outcomes for certain indications, but evidence quality varies greatly depending on the specific indication, route of administration, frequency of instillation, fecal preparation, and …
·pubmed.ncbi.nlm.nih.gov·
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
In conclusion, moderate- to high-quality evidence supported a promising use of FMT to safely induce remission in UC. However, further trials with larger sample size are still required to comprehensively analyze the delivery route, total dosage, frequency, and donor selection in FMT.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
Clinical potential of microbiota in thyroid cancer therapy - PubMed
Clinical potential of microbiota in thyroid cancer therapy - PubMed
Thyroid cancer is one of the most common tumors of the endocrine system because of its rapid and steady increase in incidence and prevalence. In recent years, a growing number of studies have identified a key role for the gut, thyroid tissue and oral microbiota in the regulation of metabolism and th …
·pubmed.ncbi.nlm.nih.gov·
Clinical potential of microbiota in thyroid cancer therapy - PubMed